Meeting
2019 ASCO Annual Meeting
A gene signature of response to radiotherapy in patients with grade II-III oligodendrogliomas.
Authors
Elizabeth Moyal
Institut Claudius Regaud, IUCT-O, Toulouse, France
Elizabeth Moyal , Julia Gilhodes , Guillaume Peyraga , Emmanuelle Uro-Coste , Damien Pouessel , Delphine Larrieu-Ciron , Catherine Carpentier , Francois Ducray , Caroline Dehais
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Central Nervous System Tumors
Citation
J Clin Oncol 37, 2019 (suppl; abstr 2041)
DOI
10.1200/JCO.2019.37.15_suppl.2041
Abstract #
2041
Poster Bd #
230
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Characterizing malignant transformation in patients with IDH-mutant glioma.
First Author: Vicki Liu
Poster
2022 ASCO Annual Meeting
Factors associated with the occurrence of myocardial infarction in patients treated for melanoma.
First Author: Xianying Pan
Poster
2020 ASCO Virtual Scientific Program
Preliminary assessment of low-intensity transcranial magnetic stimulation (TMS) during the treatment for brain glioblastomas.
First Author: Ivan A. Popov
Poster
2019 Gastrointestinal Cancers Symposium
Lung metastasis as predictor for prognosis in metastatic colorectal cancer with mutated KRAS.
First Author: Ben Boursi